Ignite Creation Date:
2025-12-24 @ 1:29 PM
Ignite Modification Date:
2026-04-18 @ 3:09 AM
Study NCT ID:
NCT02591095
Status:
COMPLETED
Last Update Posted:
2019-03-19
First Post:
2015-10-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer
Sponsor:
Centre Francois Baclesse
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-01
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-14
First Submit QC Date:
None
Study First Post Date:
2015-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-03-15
Last Update Post Date:
2019-03-19
Last Update Post Date Type:
ACTUAL